Research Frontiers (REFR) AI Stock Analysis

152 Followers

Research Frontiers

(NASDAQ:REFR)

Select Model

Rating:41Neutral

Price Target:$0.30▼(-4.44% Downside)

Action:upgraded

Date:11/06/26

REFR scores near the low end of the range, driven primarily by severely weak financials: minimal and sharply declining royalty revenue, persistent multi-million-dollar losses, nearly $1.9 million of annual cash burn against under $2 million of total assets, and shareholders' equity eroded to roughly $0.6 million with liabilities now exceeding equity. Technicals reinforce the caution, with the price below all major moving averages and negative MACD momentum, while the negative P/E and absence of a dividend offer no valuation cushion. The latest earnings call provides the main counterweight, highlighting the Gauzy settlement and production restart, expected receivable collections, intact premium automotive and growing aerospace programs, and a potentially large architectural retrofit market, but management conceded that material royalty recovery will not arrive until after the fourth quarter of 2026 and the company faces NASDAQ listing compliance pressure. The result is a highly speculative profile where any upside depends on successful supply-chain restoration and future licensing adoption rather than current performance.

Positive Factors

Capital-light licensing modelThe licensing structure can let Research Frontiers scale royalty income without matching growth with heavy factory investment. If licensees successfully commercialize SPD products, incremental revenue could carry attractive operating leverage and preserve capital for intellectual-property development.

Negative Factors

Severe revenue and profitability weaknessThe sharp revenue contraction and deeply negative profitability indicate that the current business base cannot cover its cost structure. High gross margin alone is insufficient when revenue is too small, leaving earnings dependent on a sustained recovery in commercialization and royalty activity.

Research Frontiers (REFR) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $10.99M
Dividend Yield: ―
Average Volume (3M): 1.67M
Price to Earnings (P/E): -4.4
Beta (1Y): 0.57
Revenue Growth: -69.70%
EPS Growth: -27.58%
Country: US
Employees: 5
Sector: Technology
Sector Strength: 61
Industry: Hardware, Equipment & Parts

Research Frontiers Business Overview & Revenue Model

Company Description

Research Frontiers Incorporated (REFR) stands as a global innovator, focusing on the development and commercialization of advanced light-regulating technologies and associated devices. The company's core business revolves around its proprietary Suspe...

How the Company Makes Money

Research Frontiers primarily makes money by licensing its patented SPD technology and collecting royalties tied to the sale of SPD-enabled products made by its licensees and their supply-chain partners. Its revenue model is predominantly IP-based rat...

Research Frontiers Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:-14.40%|Next Earnings Date:Mar 11, 2027

Earnings Call SentimentPositive

The call was cautiously optimistic to positive. Research Frontiers reported severe near-term financial and supply-chain damage, including lower fee income, a wider loss, limited liquidity, delayed royalty recovery, Gauzy-related uncertainty, and NASDAQ compliance issues. However, management emphasized concrete settlement and financing milestones, the planned restart of SPD production, intact automotive programs, expanding aerospace activity, strong architectural retrofit potential, new application interest, and opportunities to restore royalties once dependable film supply returns.

Positive Updates

Gauzy Settlement and Financing Enable Supply Restart

Gauzy's court-approved Israeli settlement became effective in September, additional financings closed in October, and payments began supporting the restart of SPD emulsion manufacturing in Israel and SPD film manufacturing in Germany. The Israeli settlement addresses approximately $61 million of pre-petition liabilities, while Gauzy's October financing totaled $7 million and was led by CEO Eyal Peso and other investors.

Negative Updates

Sharp Decline in Third-Quarter Fee Income

Third-quarter fee income was approximately $77,000, compared with approximately $359,000 in the third quarter of 2025, a decline of approximately 79%. Management attributed the comparison to nonrecurring government contract royalty revenue in the year-earlier quarter and the significant effect of constrained SPD material supply in the current period.

Company Guidance

Management said it does not expect a material royalty recovery until after the fourth quarter of 2026, believes receivables should all be collected this month or next month, and expects substantial amounts owed to be paid in November and December, which would alleviate or almost completely eliminate the need to raise additional funds, although any financing may be small; it also said architectural retrofit project decisions can occur in a matter of weeks rather than months or years, that architectural retrofit could surpass our other markets combined, and highlighted four automotive OEMs, two production business jets, a new light jet, and a new program with a North American aircraft manufacturer.

Research Frontiers Financial Statement Overview

Summary

Financials are very weak across all three statements. TTM revenue of roughly $0.29 million fell about 55% year-over-year, producing a $2.46 million net loss and a net margin near -835% despite high licensing gross margins of about 70%. The balance sheet has eroded sharply, with total assets down to $1.96 million and shareholders' equity collapsing to about $0.61 million, leaving obligations of $1.06 million greater than equity (debt-to-equity near 1.73x) and return on equity around -169%. Cash flow is persistently negative, with roughly -$1.86 million of operating and free cash flow, worse than prior years, and under $2 million of total assets against nearly $1.9 million of annual burn. The only mitigating factors are the asset-light, capital-efficient licensing model, negligible capex, and a small absolute debt load, but the limited runway makes additional dilutive financing likely.

Income Statement

8Very Negative

Balance Sheet

14Very Negative

Cash Flow

9Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	371.83K	1.12M	1.34M	909.60K	539.69K	1.26M
Gross Profit	283.83K	934.57K	1.07M	-1.45M	539.69K	1.26M
EBITDA	-2.30M	-1.86M	-1.05M	-1.74M	-2.49M	-1.67M
Net Income	-2.46M	-2.05M	-1.31M	-1.91M	-2.67M	-1.85M
Balance Sheet
Total Assets	1.96M	2.25M	4.04M	3.85M	5.37M	4.55M
Cash, Cash Equivalents and Short-Term Investments	644.63K	664.30K	1.99M	2.48M	4.23M	3.03M
Total Debt	1.06M	1.17M	1.30M	267.72K	464.13K	646.22K
Total Liabilities	1.35M	1.32M	1.44M	332.79K	569.59K	762.06K
Stockholders Equity	612.79K	933.63K	2.60M	3.52M	4.80M	3.78M
Cash Flow
Free Cash Flow	-1.86M	-1.33M	-790.44K	-2.30M	-2.18M	-1.81M
Operating Cash Flow	-1.86M	-1.33M	-788.82K	-2.30M	-2.18M	-1.80M
Investing Cash Flow	-257	-726	-1,623	55.59K	2.69M	-2.78M
Financing Cash Flow	1.38M	0	308.67K	484.50K	3.45M	86.26K

Research Frontiers Technical Analysis

Technical Analysis SentimentNegative

Last Price0.32

Price Trends

50DMA0.52Negative

100DMA0.50Negative

200DMA0.70Negative

Market Momentum

MACD-0.06Positive

RSI33.35Neutral

STOCH18.50Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For REFR, the sentiment is Negative. The current price of 0.32 is below the 20-day moving average (MA) of 0.40, below the 50-day MA of 0.52, and below the 200-day MA of 0.70, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 33.35 is Neutral, neither overbought nor oversold. The STOCH value of 18.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for REFR.

Research Frontiers Risk Analysis

Research Frontiers disclosed 14 risk factors in its most recent earnings report. Research Frontiers reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Research Frontiers Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

REFR against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
CPSH	49Neutral	$80.53M	495.12	0.60%	―	7.01%	―
MIND	46Neutral	$28.09M	-11.28	-5.77%	―	-28.46%	-147.43%
ODYS	44Neutral	$33.20M	-1.60	-78.20%	―	-78.30%	-4.48%
REFR	41Neutral	$12.45M	-4.39	-221.11%	―	-69.70%	-27.58%
NEON	39Underperform	$10.57M	-1.35	-32.76%	―	-2.32%	-180.18%

* Technology Sector Average

Performance Comparison

REFR and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
REFR	Research Frontiers	0.32	-1.31	-80.56%
MIND	Mind Technology Inc	2.96	-8.11	-73.26%
NEON	Neonode	0.58	-1.55	-72.77%
CPSH	CPS Technologies Corp.	4.06	0.69	20.47%
ODYS	Odysight.Ai Inc.	1.78	-1.80	-50.28%
HOLO	Microcloud Hologram Inc.	1.18	-2.00	-62.89%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026

Research Frontiers AI Stock Analysis